Dr. Nishitani is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Longwood Ave
Boston, MA 02115Phone+1 617-355-6000
Education & Training
- Boston Children’s Hospital/Boston Medical CenterFellowship, Pediatric Hematology/Oncology, 2020
- Dana-Farber Cancer InstituteResidency, 2023
- University of ChicagoChief Residency, Pediatrics, 2019 - 2020
- University of ChicagoResidency, Pediatrics, 2016 - 2019
- Virginia Commonwealth University School of MedicineClass of 2016, MD
- Duke UniversityBS, Biology, 2007 - 2011
Certifications & Licensure
- MA State Medical License 2020 - 2025
- IL State Medical License 2016 - 2020
- American Board of Pediatrics Pediatrics
Publications & Presentations
PubMed
- Pediatric Transplant and Cellular Therapy Consortium RESILIENT Conference on Pediatric Chronic Graft-Versus-Host Disease Survivorship After Hematopoietic Cell Transpla...Pooja Khandelwalhl, Jonathan D Fish, Lev Gorfinkel, Gregory M T Guilcher, Jonathan Howell
Transplantation and Cellular Therapy. 2025-02-12 - Engraft: A Collaborative Learning Health Network for Enhanced Transplant and Cellular Therapy Outcomes.Christopher E Dandoy, Jeffery J Auletta, Priscila Badia, Alan Bidgoli, Nancy M Daraiseh
Transplantation and Cellular Therapy. 2024-12-30 - 2 citationsAnaplastic sarcoma of the kidney (DICER1-sarcoma of the kidney): A report from the International Pleuropulmonary Blastoma/DICER1 Registry.Peter J Schoettler, Caroline C Smith, Miki Nishitani, Anne K Harris, Alexander T Nelson
Pediatric Blood & Cancer. 2024-08-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: